Swisher Daniel N JR 4
4 · CORCEPT THERAPEUTICS INC · Filed May 14, 2025
Insider Transaction Report
Form 4
Swisher Daniel N JR
Director
Transactions
- Exercise/Conversion
Common Stock
2025-05-12$14.08/sh+400$5,632→ 2,200 total - Sale
Common Stock
2025-05-12$71.55/sh−400$28,620→ 0 total - Exercise/Conversion
Common Stock
2025-05-12$12.13/sh+1,800$21,834→ 1,800 total - Sale
Common Stock
2025-05-12$72.17/sh−1,800$129,906→ 400 total - Exercise/Conversion
Stock option (right to buy)
2025-05-12−1,800→ 0 totalExercise: $12.13Exp: 2027-05-24→ Common Stock (1,800 underlying) - Exercise/Conversion
Stock option (right to buy)
2025-05-12−400→ 12,100 totalExercise: $14.08Exp: 2028-08-20→ Common Stock (400 underlying)
Footnotes (3)
- [F1]The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on August 1, 2024 in effect at the time of this transaction.
- [F2]Fully exercisable.
- [F3]The Reporting Person previously transferred 12,500 shares underlying the stock option to his ex-spouse. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.